HSIC

Henry Schein Inc

HSIC, USA

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The company offers dental merchandise, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, and PPE products; dental equipment, such as dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as equipment repair; and branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, and vitamins. It also provides financial services on a nonrecourse basis, education services for practitioners, consulting, and other services; and consumable merchandise under its own brand. In addition, the company manufactures, markets, and sells dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other health care-related products and services. Further, it is involved in the development and distribution of practice management software, e-services, and other products to health care providers. The company serves customers in dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

https://www.henryschein.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
HSIC
stock
HSIC

Henry Schein, Inc.'s (NASDAQ:HSIC) Shareholders Might Be Looking For Exit 富途牛牛

Read more →
HSIC
stock
HSIC

Westwood Holdings Group Inc. Invests $20.63 Million in Henry Schein, Inc. $HSIC MarketBeat

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$77

Analyst Picks

Strong Buy

3

Buy

4

Hold

8

Sell

0

Strong Sell

1

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Earnings Ratio (P/E)

-

High

23.52

Low ≥ 50

High ≤ 10

Price to Book Ratio (P/B)

-

Very High

2.76

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

3.01 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

0.91 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

4.22 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

1.84

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 105.11% of the total shares of Henry Schein Inc

1.

Kohlberg Kravis Roberts & Co LP

(12.9069%)

since

2025/06/30

2.

Vanguard Group Inc

(10.6637%)

since

2025/06/30

3.

BlackRock Inc

(6.022%)

since

2025/06/30

4.

Artisan Partners Limited Partnership

(5.3288%)

since

2025/06/30

5.

JPMorgan Chase & Co

(5.1561%)

since

2025/06/30

6.

State Street Corp

(4.31%)

since

2025/06/30

7.

American Century Companies Inc

(3.7593%)

since

2025/06/30

8.

Amvescap Plc.

(3.7495%)

since

2025/06/30

9.

FMR Inc

(3.0583%)

since

2025/06/30

10.

Palestra Capital Management LLC

(2.8874%)

since

2025/06/30

11.

Vanguard Total Stock Mkt Idx Inv

(2.6831%)

since

2025/07/31

12.

Geode Capital Management, LLC

(2.592%)

since

2025/06/30

13.

Vanguard 500 Index Investor

(2.485%)

since

2025/07/31

14.

Southpoint Capital Advisors LP

(2.3089%)

since

2025/06/30

15.

Vanguard Small Cap Index

(2.0707%)

since

2025/07/31

16.

Fiduciary Management, Inc. of Milwaukee

(2.0219%)

since

2025/06/30

17.

Dimensional Fund Advisors, Inc.

(2.0097%)

since

2025/06/30

18.

Ameriprise Financial Inc

(1.8693%)

since

2025/06/30

19.

JPMorgan Mid Cap Value L

(1.8499%)

since

2025/07/31

20.

Burgundy Asset Management Ltd

(1.8203%)

since

2025/06/30

21.

JPM US Mid Cap Value-Composite

(1.8141%)

since

2025/06/30

22.

Invesco S&P 500® Equal Weight ETF

(1.6399%)

since

2025/08/29

23.

American Century U.S. Mid Cap Value

(1.5846%)

since

2025/06/30

24.

American Century Mid Cap Value Inv

(1.5846%)

since

2025/06/30

25.

Sachem Head Capital Management LP

(1.3636%)

since

2025/06/30

26.

Steadfast Capital Management LLC

(1.3345%)

since

2025/06/30

27.

Vanguard Small Cap Value Index Inv

(1.3323%)

since

2025/07/31

28.

Lyrical Asset Management LP

(1.3229%)

since

2025/06/30

29.

JPMorgan Value Advantage L

(1.3218%)

since

2025/07/31

30.

Clarkston Capital Partners, LLC

(1.3093%)

since

2025/06/30

31.

Fidelity 500 Index

(1.2723%)

since

2025/07/31

32.

SPDR® S&P 500® ETF

(1.2151%)

since

2025/08/31

33.

iShares Core S&P 500 ETF

(1.208%)

since

2025/08/31

34.

Fidelity Low-Priced Stock

(1.2064%)

since

2025/06/30

35.

FMI Common Stock Investor

(1.0844%)

since

2025/06/30

36.

Invesco Comstock A

(1.076%)

since

2025/07/31

37.

Invesco Large Cap Value

(1.0683%)

since

2025/06/30

38.

Columbia Contrarian Core Inst

(0.9514%)

since

2025/07/31

39.

Folksam LO Världen

(0.9449%)

since

2025/07/31

40.

Columbia Contrarian Large Cap Core

(0.9252%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

1.3

Latest Release

Date

2025-09-30

EPS Actual

1.38

EPS Estimate

1.28

EPS Difference

0.1

Surprise Percent

7.8125%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(4)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(3)
Economic Moat
Wide Moat Company(6.3)
GARP
Fair GARP(5)
Growth
Moderate Growth(4)
Momentum
Moderate Momentum(4)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Moderate Quality(5.5)
Value
Fair Value(5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.